Physician
Hudson MD Group
Hudson MD Group was paid $5.89M by Medicaid between Jul 2020 and Dec 2024, across 222 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.
33Billing provider infoHUDSON MD GROUP
ENGLEWOOD CLIFFS, NJ 07632
ENGLEWOOD CLIFFS, NJ 07632
33aNPI1497301998assigned 08/12/2019
33bProvider typeInternal Medicine Physician
28Total paid$5.89M
24GClaims480,036
24DCodes billed222
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New Jersey
Rank by total paid#14 of 1,027
Median peer was paid$30K
This provider vs. median198×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 2,883 | $98K | |
| 2021 | 25,287 | $943K | |
| 2022 | 131,597 | $1.45M | |
| 2023 | 161,931 | $1.59M | |
| 2024incomplete | 158,338 | $1.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 54,446 | 43,663 | $2.47M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 29,869 | 24,617 | $1.23M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 5.7% | 3,674 | 3,494 | $337K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.7% | 4,947 | 4,203 | $159K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.4% | 3,319 | 2,911 | $141K |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | 1.5% | 567 | 266 | $87K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.2% | 650 | 558 | $69K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.0% | 1,879 | 1,514 | $61K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,019 | 944 | $56K |
| 99441 | <1% | 1,561 | 1,351 | $54K | |
| 99254 | <1% | 661 | 601 | $52K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,439 | 4,872 | $51K |
210 more codes
| 80061 | Lipid panel | <1% | 11,742 | $51K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,983 | $50K |
| 99457 | <1% | 6,753 | $49K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 626 | $49K |
| 93000 | <1% | 8,057 | $43K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 9,293 | $42K |
| L3020 | Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each | <1% | 190 | $38K |
| 99454 | <1% | 4,323 | $38K | |
| 93880 | <1% | 1,008 | $36K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 11,255 | $34K |
| 80053 | Comprehensive metabolic panel | <1% | 11,257 | $33K |
| 93224 | <1% | 693 | $32K | |
| 76830 | Ultrasound, transvaginal | <1% | 463 | $30K |
| 36415 | Collection of venous blood by venipuncture | <1% | 26,755 | $26K |
| 90686 | <1% | 1,510 | $25K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,949 | $23K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 556 | $19K |
| 99442 | <1% | 778 | $19K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 426 | $18K |
| 93015 | <1% | 340 | $18K | |
| 80050 | General health panel | <1% | 749 | $18K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 942 | $17K |
| 93923 | <1% | 533 | $16K | |
| 95720 | <1% | 288 | $16K | |
| 86141 | <1% | 3,228 | $14K | |
| 90688 | <1% | 1,265 | $14K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 1,203 | $13K |
| 84439 | <1% | 4,256 | $12K | |
| 82607 | <1% | 2,484 | $12K | |
| 11730 | <1% | 276 | $11K | |
| 93970 | <1% | 245 | $11K | |
| 83721 | <1% | 10,497 | $11K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 132 | $11K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 197 | $10K |
| 90682 | <1% | 200 | $10K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 500 | $10K |
| 84153 | <1% | 1,457 | $9K | |
| 82746 | <1% | 1,952 | $9K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 3,186 | $8K |
| 99458 | <1% | 1,534 | $8K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 648 | $7K |
| 83735 | <1% | 3,792 | $7K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 805 | $7K |
| 99490 | Ccm add 20min | <1% | 1,027 | $7K |
| 99497 | <1% | 1,142 | $6K | |
| 99401 | <1% | 480 | $6K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 348 | $6K |
| 64450 | <1% | 203 | $5K | |
| 84100 | <1% | 3,793 | $5K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 110 | $5K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 2,194 | $5K |
| 99051 | <1% | 618 | $5K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 501 | $5K |
| 93976 | <1% | 118 | $5K | |
| 81003 | <1% | 6,345 | $5K | |
| 90656 | <1% | 157 | $4K | |
| 99397 | <1% | 308 | $4K | |
| 82977 | <1% | 1,772 | $4K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 2,603 | $4K |
| 93018 | <1% | 576 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 629 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 64 | $3K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 339 | $3K |
| 90658 | <1% | 200 | $3K | |
| 99403 | <1% | 61 | $3K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 453 | $3K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 63 | $3K |
| 99426 | <1% | 258 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 241 | $3K |
| 83615 | <1% | 1,238 | $3K | |
| 84550 | <1% | 2,024 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,494 | $2K |
| 84154 | <1% | 431 | $2K | |
| 20550 | <1% | 177 | $2K | |
| G0420 | Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour | <1% | 75 | $2K |
| 82043 | <1% | 1,636 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,659 | $2K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 34 | $2K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 65 | $2K |
| 82570 | <1% | 1,651 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 525 | $2K |
| 99386 | <1% | 15 | $2K | |
| 80076 | <1% | 521 | $2K | |
| 96112 | <1% | 903 | $2K | |
| 95923 | <1% | 51 | $2K | |
| 93016 | <1% | 298 | $2K | |
| 3079F | <1% | 6,806 | $2K | |
| 11000 | <1% | 78 | $1K | |
| 94060 | <1% | 88 | $1K | |
| 3074F | <1% | 14,144 | $1K | |
| 99406 | <1% | 349 | $1K | |
| 3044F | <1% | 5,671 | $1K | |
| 90662 | <1% | 1,000 | $1K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 286 | $1K |
| 3008F | <1% | 30,336 | $1K | |
| 99050 | <1% | 237 | $1K | |
| 95921 | <1% | 51 | $1K | |
| 93925 | <1% | 86 | $1K | |
| 93890 | <1% | 33 | $1K | |
| 93886 | <1% | 33 | $1K | |
| 99173 | <1% | 419 | $943.48 | |
| 99424 | <1% | 44 | $912.88 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 62 | $863.13 |
| 3078F | <1% | 15,203 | $828.03 | |
| 92551 | <1% | 93 | $812.57 | |
| 10060 | <1% | 43 | $780.97 | |
| 90756 | <1% | 62 | $732.56 | |
| 83970 | <1% | 103 | $710.85 | |
| 99453 | <1% | 229 | $686.16 | |
| J0280 | Injection, aminophyllin, up to 250 mg | <1% | 292 | $653.68 |
| 96127 | <1% | 209 | $642.98 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,515 | $617.58 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,735 | $609.06 |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 87 | $603.63 |
| 82728 | <1% | 211 | $592.36 | |
| 11056 | <1% | 93 | $548.62 | |
| 3077F | <1% | 3,139 | $547.90 | |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | <1% | 53 | $526.58 |
| 76857 | <1% | 17 | $518.93 | |
| 3075F | <1% | 4,626 | $513.30 | |
| 82550 | <1% | 296 | $502.84 | |
| 94010 | <1% | 31 | $474.85 | |
| 99307 | <1% | 84 | $457.61 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 146 | $435.32 |
| 93978 | <1% | 166 | $429.43 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 18 | $420.58 |
| 84480 | <1% | 67 | $399.94 | |
| 11721 | <1% | 57 | $365.32 | |
| 84403 | <1% | 40 | $364.80 | |
| 99335 | <1% | 12 | $340.50 | |
| 90674 | <1% | 14 | $309.41 | |
| 83550 | <1% | 169 | $283.25 | |
| 84402 | <1% | 17 | $245.10 | |
| 83540 | <1% | 186 | $237.68 | |
| 82248 | <1% | 90 | $232.02 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 39 | $222.80 |
| 1159F | <1% | 5,636 | $211.00 | |
| 84270 | <1% | 16 | $203.65 | |
| 3080F | <1% | 911 | $178.00 | |
| 1160F | <1% | 4,976 | $177.00 | |
| 3051F | <1% | 551 | $164.00 | |
| 83001 | <1% | 25 | $147.22 | |
| 90694 | <1% | 43 | $132.86 | |
| 82670 | <1% | 12 | $94.53 | |
| 1126F | <1% | 1,055 | $70.00 | |
| 83002 | <1% | 12 | $63.52 | |
| 90653 | <1% | 13 | $63.10 | |
| 97802 | <1% | 329 | $54.15 | |
| 51798 | <1% | 13 | $37.57 | |
| 1170F | <1% | 1,705 | $36.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 13,810 | $24.00 |
| 87210 | <1% | 14 | $23.88 | |
| 3072F | <1% | 90 | $17.08 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 15,652 | $16.00 |
| 82962 | <1% | 75 | $10.78 | |
| 82247 | <1% | 264 | $10.57 | |
| 1125F | <1% | 362 | $10.00 | |
| 1123F | <1% | 763 | $8.00 | |
| 99072 | <1% | 113 | $7.00 | |
| 1158F | <1% | 348 | $6.05 | |
| 1124F | <1% | 586 | $6.00 | |
| 3052F | <1% | 19 | $5.00 | |
| 3061F | <1% | 291 | $4.00 | |
| 4010F | <1% | 333 | $4.00 | |
| 0134A | <1% | 14 | $3.00 | |
| M1189 | Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed | 0% | 273 | $0.00 |
| 1090F | 0% | 793 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 271 | $0.00 |
| 3725F | 0% | 5,339 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,485 | $0.00 |
| 3050F | 0% | 1,494 | $0.00 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 1,439 | $0.00 |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | 0% | 1,746 | $0.00 |
| 4013F | 0% | 310 | $0.00 | |
| 3016F | 0% | 1,033 | $0.00 | |
| G9276 | Documentation that patient is a current tobacco user | 0% | 75 | $0.00 |
| G8785 | Blood pressure reading not documented, reason not given | 0% | 58 | $0.00 |
| 3288F | 0% | 501 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 150 | $0.00 |
| 1100F | 0% | 560 | $0.00 | |
| G8404 | Lower extremity neurological exam performed and documented | 0% | 13 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 129 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 191 | $0.00 |
| 1032F | 0% | 88 | $0.00 | |
| 2022F | 0% | 12 | $0.00 | |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 16 | $0.00 |
| G8421 | Bmi not documented and no reason is given | 0% | 14 | $0.00 |
| 2028F | 0% | 15 | $0.00 | |
| G8416 | Clinician documented that patient was not an eligible candidate for footwear evaluation measure | 0% | 196 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 3,632 | $0.00 |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 2,092 | $0.00 |
| 2023F | 0% | 203 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 9,173 | $0.00 |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 785 | $0.00 |
| 1036F | 0% | 4,119 | $0.00 | |
| 99000 | 0% | 1,085 | $0.00 | |
| 1000F | 0% | 2,334 | $0.00 | |
| 1111F | 0% | 658 | $0.00 | |
| 0509F | 0% | 274 | $0.00 | |
| 3017F | 0% | 192 | $0.00 | |
| 3048F | 0% | 1,549 | $0.00 | |
| 1101F | 0% | 1,454 | $0.00 | |
| 3049F | 0% | 1,210 | $0.00 | |
| 1030F | 0% | 725 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 132 | $0.00 |
| 1157F | 0% | 239 | $0.00 | |
| G2178 | Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation | 0% | 142 | $0.00 |
| G8410 | Footwear evaluation performed and documented | 0% | 13 | $0.00 |
| 3014F | 0% | 67 | $0.00 | |
| 81099 | 0% | 104 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDHARMARAJ, RAJAVELU (ACCOUNTS MANAGER)